Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23andMe to Cut 40% of Its Staff
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on using customers’ DNA data to aid in drug discovery.
23andMe cuts 40% of its workforce and discontinues therapeutics division
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs. The latest restructuring efforts were announced by 23andMe on Monday.
23andMe cuts 40% of its workforce
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to "streamline operations and reduce costs."
23andMe, genetic testing
23andMe customer? Here's what to know about the privacy of your genetic data.
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
What 23andMe business troubles could mean for millions of users' genetic data
On Tuesday, 23andMe released its latest earnings report, showing revenue dipped 12% in the last quarter and share prices fell. The company has faced additional struggles over the past several months,
What 23andMe business troubles could mean for users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers' DNA and other data. The company announced Monday that it would lay off around 40% of its workforce -- about 200 employees -- and close its drug development arm in an attempt to cut costs.
2d
on MSN
After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
Hosted on MSN
18h
23andMe Cuts 40% of Staff as Revenue Falls
But it’s not just staffing changes:
23andMe
is also shutting down its entire therapeutics division, which had been working ...
medtechdive
1d
23andMe to lay off more than 200 employees amid business struggles
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the ...
7h
23andMe lays off 40% of workers, reports losses amid uncertain future
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
2d
on MSN
23andMe is ending its cancer research program and slashing over 200 jobs
Though 23andMe says the restructuring plan will cost it around $12 million, it expects to save more than $35 million as a ...
2d
23andMe reports sales decline day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
Yahoo Finance
1d
Q2 2024 23andMe Holding Co. Earnings Call
Anne
Wojcicki
; Chairman of the Board, President, Chief Executive Officer, Co-Founder;
23andMe
Holding Co. Joseph Selsavage; Interim Chief Financial Officer, Chief Accounting Officer;
23andMe
...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback